TSS
NYMX

Two Sigma Securities’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Two Sigma Securities’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-11,737
Closed -$2.23K – 3666
2023
Q2 		$2.23K Sell
11,737
-9,585
-45% -$3.77K ﹤0.01% 2695
2023
Q1 		$7.25K Buy
21,322
+1,250
+6% +$508 ﹤0.01% 2495
2022
Q4 		$6.49K Buy
20,072
+8,657
+76% +$3.13K ﹤0.01% 2428
2022
Q3 		$5K Buy
+11,415
New +$4.54K ﹤0.01% 2483

Other funds holding NYMX

DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return
FCFC
First Citizens Financial Corp Mason City, Iowa $239M AUM 26.56% 1-Year Est. Return
CAM
Cubic Asset Management Boston, Massachusetts $422M AUM 29.18% 1-Year Est. Return
ODIJL
One Day In July LLC Burlington, Vermont $1.25B AUM 12.08% 1-Year Est. Return

Two Sigma Securities's NYMX Position: Q3 2023 in Review

Two Sigma Securities sold out of Nymox Pharmaceutical Corp (NYMX) in Q3 2023, closing a stake of 11,737 shares — an estimated $2.23K sold.

Two Sigma Securities first reported a position in NYMX in Q3 2022 and held it in 4 quarters. The position peaked at $7.25K in Q1 2023. 5 funds tracked by Wall St. Rank hold NYMX as of Q3 2023.

  • Two Sigma Securities reported no remaining Nymox Pharmaceutical Corp position as of Q3 2023 after selling out during the quarter.
  • Two Sigma Securities sold 11,737 Nymox Pharmaceutical Corp shares in Q3 2023, an estimated $2.23K.
  • Two Sigma Securities first reported a position in Nymox Pharmaceutical Corp in Q3 2022 and held it in 4 quarters.
  • Two Sigma Securities's Nymox Pharmaceutical Corp position peaked at $7.25K in Q1 2023.
  • 5 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q3 2023.

Based on Two Sigma Securities's 13F filing for Q3 2023, filed 14 Nov 2023.